chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Have not been able to lift my arm up to certain extent; I cannot stand the pain; She said she cannot lift her arm/horrible pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 08Jul2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "not recovered", described as "She said she cannot lift her arm/horrible pain"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "Have not been able to lift my arm up to certain extent"; PAIN (non-serious), outcome "unknown", described as "I cannot stand the pain". The event "she said she cannot lift her arm/horrible pain" was evaluated at the physician office visit. Therapeutic measures were taken as a result of pain in extremity.  Additional information: Patient described it as horrible pain that keeps on getting worse every time that when she cannot even put on a jacket. She said she's never had this pain before, and that it just happened after her 2nd dose. She said she already consulted her physician and was told that a lot of patients have the same problem as hers. She was told that hers was not normal because the symptoms do not last for more than 4-5 weeks, but hers lasted for months.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Successfully staged PCI DES LM to LCX, with serial PTCA and intravascular lithotripsy. Ambulating with cardiac rehab without difficulty for discharge. This admission was within 6 weeks of receiving the COVID vaccine.
Information has been received from a physician concerning a female who "one month ago," on approximately 12-MAY-2008 was vaccinated with a first dose of GARDASIL vaccine (yeast) (lot# and route not reported). The reporter noted that the patient broke out in hives, was dizzy and went to the emergency room. No additional information was provided. Additional information has been requested.
This is a spontaneous report based on the information received from contactable consumer/patient (report number: UNT-2021-004365). A 54-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not provided), at the age of 54, via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. The patient took oral Orenitram (treprostinil diolamin) from Sep 2020 to an unspecified date, at unspecified dose and ongoing; oral Orenitram (treprostinil diolamin) 0.125mg, extended release, from an unspecified date to an unspecified date, at unspecified dose and ongoing and oral Orenitram (treprostinil diolamin) 3.625mg, 3x/day for pulmonary arterial hypertension. Medical history included ongoing pulmonary arterial hypertension. On an unknown date, patient was very sick. She reported she received the COVID-19 vaccine and became very sick for 8 days afterward. PO Orenitram dose was not changed due to the event of illness. The reporter did not provide causality for the event of illness. At the time of report, the outcome of illness recovered. No follow-up attempts needed. Information about batch/lot number cannot be obtained.
very allergic; Initial information was received on 10-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer or Non-health care professional.  This case involves an adult patient (unknown age and unknown gender) who experienced very allergic, (hypersensitivity) while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number not reported and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious very allergic (hypersensitivity) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. Medication Details and reason for taking the medicine was not provided.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on batch number for this case.
Chicken pox like, soreness, tenderness, red, hardness, she said cellulitis, swelling, red dots, tired
dizziness; sweating; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021 at 8:50 AM, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating). On 08-Apr-2021 at 10:14 AM, DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (120-80 mmHg): 140/98 mmHg (High) 08:50 am (20 min after vaccination) and 120/82 mmHg (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Body temperature (97.7-99.5): 98.0  degree fahrenheit (normal) 08:50 am (20 min after vaccination) and 98.0  degree fahrenheit (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Heart rate (60-100): 62 beats per minute (normal) 08:50 am (20 min after vaccination) and 57 beats per minute (Low) 10:14 am (prior leaving the facility). On 08-Apr-2021, Oxygen saturation (96-100): 98% (normal) 08:50 am (20 min after vaccination) and 97% (normal) 10:14 am (prior leaving the facility).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reported.  Patient was monitored for 1 hour and 25 minutes by one of  registered nurses.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Followup received: contains no new information. On 19-Jul-2021: Significant FU : Patient details provided
granulomas at the injection sites/ lumps have occurred, and they are exactly at the injection sites and above her lip; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE GRANULOMA (granulomas at the injection sites/ lumps have occurred, and they are exactly at the injection sites and above her lip) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product POLY-L-LACTIC ACID (SCULPTRA) injection for an unknown indication.    No Medical History information was reported.   On 13-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started POLY-L-LACTIC ACID (SCULPTRA) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE GRANULOMA (granulomas at the injection sites/ lumps have occurred, and they are exactly at the injection sites and above her lip). At the time of the report, INJECTION SITE GRANULOMA (granulomas at the injection sites/ lumps have occurred, and they are exactly at the injection sites and above her lip) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  On 09-Jun-2021, it was reported that the patient was injected with Sculptra into the cheek area. The patient had granulomas at the injection sites and stated that the week after Easter 2022, 07-Apr-2022 or 08-Apr-2022, the patient noticed a lump on their lower right cheek. The consumer additionally reported that since then, other lumps had occurred, and they were exactly at the injection sites and above their lip. The patient had Radiesse in May-2021.~  No treatment information was provided.
pt recvd vax & became ill about 2 1/2 hrs p/vax; c/o initially stomach cramps, fever, chills & then vomiting; felt faint, was pale;
measles like rash, diarrhea, vomited once, fever;tx fluids, APAP, Tigan supp;
Had flu shot on Sep 13, 2009. Had no reaction to the shot at all - called research co & informed about diagnosis of Guillain Barre March 9 started having numbness & tingling in his feet. It progressed up the leg. He went to bed one night and legs felt like they were asleep but he couldn't wake them. He went to the doctor March 12 09 and PCP sent him to the hospital. Diagnosed with Guillain Barre Syndrome - slowly recovering.
Immediately when the shot was administered (I only received one), my entire body broke out into a cold sweat and I almost lost consciousness. I started developing hives very soon after the shot, and after numerous tests and visits to multiple doctors I was diagnosed with delayed pressure urticaria.  My condition has severely impacted my life.  Not only have I spent countless hours and money on doctor visits and testing medications for this condition, but I am uncomfortable every single day of my life.  I develop painful, itchy, embarassing hives on any surface of my body that receives pressure.  This includes sitting, standing, sleeping, leaning, exercise, working, etc.  I have also developed severe intolerances to drugs - some of which I require for other medical conditions.  I wake up every morning covered head to toe, wake up every night itching and sometimes prevents me from attending work depending on the area the hives affect on given day.
ARM PAIN, CHILLS, FATIGUE, MALAISE, MUSCLE ACHES Narrative:
6 cm x 4 cm urticarial, erythematous reaction on (L) delt, 10m after vaccine administration.
Started Sunday, 3/7  late night at 3:00 a.m. - diarrhea (1 time).  Next morning, Monday, 3/8 dealt with nausea, fatigue, headache which lasted until Wednesday, 3/10.  Two episodes of quick flash of dizziness on Wednesday and again on Friday, 3/12.  Did not realize I had the symptoms of  Covid arm (small knot, small area of redness, warmth below the injection site) until I examined my arm on Monday, 3/15.  As of today, 3/18 the knot has resolved, but the area of redness has increased over the past three days and warmth are still present.
Information has been received from a registered nurse concerning an 82 year old male on dialysis with hypertension, enlarged prostate, chronic anaemia, trigeminal neuralgia, obesity and drug hypersensitivity to vancomycin (rash) and a history of haemorrhoidectomy who on 22-JUL-2006 was vaccinated with IM, into the right deltoid, with a 0.5 ml dose of Pneumovax 23 (lot #651373/0320F). Concomitant therapy included LASIX, TEGRETOL, baclofen, FLOMAX, atenolol, FOLBEE, TUMS, NORVASC, EPOGEN and HECTOROL. On 22-JUL-2006, the patient developed pain, redness and swelling of the right upper arm. On 23-JUL-2006, the patient presented to the emergency department with pain, redness and swelling of the right upper arm. A line was drawn around the site. On 24-JUL-2006, the patient returned to the emergency department and the affected site had grown approximately 3 inches beyond the line, down to the elbow. The patient was diagnosed with cellulitis. The patient received 2 grams of ROCEPHIN and was ordered to take CEFTIN, 500 mg for the next 14 days. At the time of the report, the cellulitis persisted and the patient was unable to use his arm. Cellulitis was considered to be disabling and an other important medical event. Additional information has been requested.
Received vaccine at 1100.   Patient woke up at 0151 with headache, chills and body aches.  Symptoms the same this afternoon at 1200.
Patient states two hours following vaccine injection, she experienced dizziness, feeling faint and an erratic heart (40-83 beats per minute) Breathing was fine, oxygen saturation was at 98. These symptoms lasted for about 2 hours.
15 days post varivax, developed fever (104), joint pain, headache, cough, 3 lesions on back/buttocks, 2 lesions on abdomen. Lesions have erythematous base with raised vesicle with clear fluid. Anterior cervical adenopathy. Fresh vesicles still today. Brother had varivax same day and has similar reaction.
I had a strange feeling in the left side of my face that I wasn't sure if it was a reaction or not.  It happened within the first 15 minutes but did not last more than 30 minutes.  I did not experience anything else until the first evening when my arm was very sore.  The next day my arm was more sore and I had a mild circular red mark around the injection site and the arm was much harder on that side.  I also felt a little in my back and neck.  By the second day in the evening the only thing I felt was pain in the arm which eventually traveled into my armpit by day 3.  It wasn't until day 5 that all the pain was completely gone.  I may have experienced fatigue the first two days also.
Vomiting and fever.  Vomited 4-5 times over 18 hours.  Fever 99.6.  Able to keep fever down with tylenol
7/10 Aching hips and shoulders , 5/10 pain at injection site, stomach pain, headache, fatigue
OFF LABEL DOSING FREQUENCY; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient had previously received first dose of covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number is series: 1) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number is series: 1). The patient had previously received second dose of covid-19 vaccine ad26.cov2.s (dose number is series: 2) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number is series: 2). The patient received third dose of covid-19 vaccine ad26.cov2.s (dose number is series: 3) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The product was associated with Off label use (off label dosing frequency) (dose number is series: 3). The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of off label dosing frequency was not reported. This report was non-serious.
I had some bad cough; This is a spontaneous report from a contactable consumer or other non hcp.   A patient of unspecified age and gender received BNT162b2 (CONMINTARY, Solution for injection, Lot No: was not reported, NDC, UPC number and expiry date was not provided), via an unspecified route of administration on an unspecified date as 1stdose, single for covid-19 immunisation. The patient medical history and Concomitant medication were not reported. The patient experienced i had some bad cough (cough) (non-serious) on an unspecified date. The clinical outcome of the event was unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Red rash on arm, raised small blister, black and blue, growing from small circle spreading a bit
received the Moderna Monovalent Booster instead of the bivalent vaccine; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine).    No concomitant medications were reported.  It was reported that, the patient received the Moderna Monovalent Booster instead of the bivalent vaccine. The nurse stated that, this happened because the monovalent vaccine with purple border was labeled as booster dose.  No adverse event noted.  No treatment medications were reported.
around May25th she reports her legs started "twitching/jolts" and "legs hurt all the time", and "legs feeling a little weaker". She reports that after her 1st dose her legs were aching for a couple days. She was referred to medical center for a muscle test
Patient received a dose of Moderna bivalent booster on 10/06/2022. He received additional Bivalent booster (Pfizer) on 12/28/2022 outside of current CDC guidelines. He is currently being monitored for 72 hours.
mom called 25JAN95 RE: 3 red spots on back & in mouth; wondered if r/t immun; states had same occurrence on 10FEB94 w/DTP/HIB & OPV; pt has generalized rash, low grade fever, fussiness; has URI & a rash @ this time; has not checked w/MD;
This spontaneous report as received from a other health professional refers to a unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On 15-FEB-2015, unspecified number of patients were vaccinated with improperly stored doses of ZOSTAVAX, lot number reported as K021953, expiration date 10-FEB-2916. Dose and route were not reported. No co-suspect and concomitant therapies were reported. No adverse events reported. This is one of several reports from the same source. Additional information has been requested.
Red bullseye, swelling in deltoid, hot to touch. Left superclavicular lymph node swollen.
This spontaneous report was received from a nurse practitioner refers to an unspecified patient of unknown age. The patient's pertinent medical history, drug reaction/allergies and concomitant medications were not reported. On 14-JUL-2016, the patient was vaccinated with an improperly stored (Oka/Merck) VARIVAX (lot # M000761 and expiry date 06-JAN-2018). The temperature excursion was at 10.4F for 15 minutes. There was no previous temperature excursion. Additional information has been requested.
An area of erythema 50 x 30 mm developed on the skin over the right deltoid nearly 6 months after the 2nd dose of Moderna. The area is slightly tender to touch. The area is slightly raised. First dose given on the right arm on 21 Jan 2021. Second dose given on left arm on 19 Feb 2021. The erythema has mild pruritis. No other systemic symptoms. No medical care sought for the erythema at this point.
pt exp vomiting, diarrhea & fever of 103 & was hosp;while in the hosp pt devel rubella-like rash;unspecified blood test were performed;
Patient said after 1 hour she had severe pain in her arm/ shoulder and tried taking tylenol for it. That did not relieve the pain so she went to the ER and they diagnosed her with tendonitis from the shot and gave her tylenol with codeine. As of yester day when she came into our store to talk with employee who was not here, but had administered the shot she was still sore in that arm/shoulder. She only wanted to speak with the RPh that administered the shot not get anyone in trouble.
CoughWheeze ASTHMA/BRONCHIECTASIS EXACERBATION, EXCESS MUCUS, sob Narrative:
Received flu shot on 11/17/05 at 10:20am. At 3:30 that afternoon "bad coughing", fever (101), joints aching, dull eyes.
Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline.  Pt received 2nd dose prepared with same incorrect diluent on 1/13/22  No Clinical concerns were reported.
pt w/t102.5 & rash on upper body following vax; seen @ hosp ER
initial symptoms started at ~ 8-12 hr post inj on FRI:  fever, chills, fatigue, muscle pain (generalized), back pain from sacrum to occiput, through cranium to behind eyes, nausea, loose stools, exhaustion, arm swelling (6" diameter) with bandaid indented becoming hard (feeling a little like cellulitis).  routinely measure pO2 and body temp--both spiked; resp rate went from normal pattern of 10-12 to 25; night time HR went from low 60's to the 100's; pO2 went from 96-98 to 89-91 (Innovo PulseOx)Treated with sleep (slept from 8PM night of shot until 48 hours after the shot), fluids, hot water bottles, arnica (I can't take NSAIDS), vit C, zinc megadoses;  by ~36 hours post injection I started wheezing and coughing deeply but non productive, both nasal passages were/are open, feels as though phlegm is stuck at bronchi.  By 48 hours, I was feeling better except chest, ribs, head, and neck and was experiencing 1-3" episodes of spasmodic coughing, wheezing, SOB; Occurred every 20-30 minutes and leaving me physically exhausted.  Sunday night slept with 4 pillows; went to see acute respiratory care clinic, evaluated, COVID-PCR was negative, temperature was normal by statistics (I tend to be colder; baseline temps between 32-33oC and over past week has ranged between 35-39oC).  Sent home with albuterol inhaler, mucinex (which I take at night), and flonase (my nostrils remain clear).  Current status:  extreme fatigue, high resting HR, minimal activity (walking) increases it to the 100s--not normal for me), and continued episodic bronchospasm (uncontrolled) with SOB and diaphragmatic, skeletal pain.  Deep diaphragmatic breaths also trigger.  Am also treating with hot water bottles to anterior and posterior chest walls, and nebulizer treatments with eucalyptus, thyme, and rosemary.  Still megadosing on C and Zinc.  Expect to return to work tomorrow (missed 2 days) as  neurologic and orthopedic physical therapist /exercise physiologist.
Thursday morning 1/7/21, right side of face noticed jaw drooping, later progressed to bad headache, bad taste in mouth then lost sense of taste. Pain on the right side of face/jaw area. Trouble speaking. Went to ER at hospital then transferred to another ER.